European Medicines Agency

Pfizer and BioNTech on Thursday announced positive results from a clinical trial on the safety and immune response of a third dose of their Covid vaccine in children aged five through 11,…

While the BA.2 appears to have a higher transmissibility than previous sub-variants, there is no data that could suggest it causes severe disease. The BA.2 sub-variant of the coronavirus’…

Indian giants Sun Pharmaceutical Industries, Optimus Pharma, and Dr Reddy’s Laboratories are exploring the possibility of manufacturing the pill, reports suggest. On Wednesday, Pfizer…

"In the light of EMA's latest deliberation, we can go ahead with the third vaccine dose to people of all ages with a fragile immune system and to all people over 60, always six months…